Hato, Yukari <br/><br/>
Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients.  [electronic resource] 

 -  International journal of clinical oncology  Jun 2016 
 - 539-47 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1437-7772 
<br/><br/><label>Standard No.: </label>10.1007/s10147-015-0913-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>BRCA1 Protein--genetics<br/>Breast Neoplasms--chemistry<br/>Cathepsins--genetics<br/>Chemotherapy, Adjuvant<br/>DNA-Binding Proteins--genetics<br/>Disease-Free Survival<br/>Female<br/>Genotype<br/>Humans<br/>Middle Aged<br/>Neoplasm Recurrence, Local--genetics<br/>Polymorphism, Single Nucleotide<br/>Prognosis<br/>Proteins<br/>RNA, Messenger--analysis<br/>Receptor, ErbB-2--analysis<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis<br/>Tamoxifen--therapeutic use